InsidersTradesSigma
Discover the full directors' dealings record of NANOVIRICIDES, INC., a listed equity based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was reported on 10 August 2022 (Don). Among the most active insiders: BONIUK MILTON. The full history is free.
Analysts rate NANOVIRICIDES, INC. Strong Buy (bullish), based on 10 analysts. Average price target: US$57.10.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
NANOVIRICIDES, INC. is a company focused on developing antiviral treatments based on nanotechnology. It is listed on the XNAS market.